A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

March 1, 2026

Conditions

Graves' Orbitopathy

Interventions

DRUG

Methimazole

Methimazole for 72 weeks

PROCEDURE

Radioiodine or thyroidectomy

Treatment with radioiodine or with thyroidectomy

Trial Locations (1)

RECRUITING

Endocrinology Unit II, Pisa

All Listed Sponsors

lead

University of Pisa

OTHER